Evidence map›Paper›PMID 32552110›Full record

Observational studyJCO global oncology2020

Perspective of Oncology Patients During COVID-19 Pandemic: A Prospective Observational Study From India.

Joydeep Ghosh, Sandip Ganguly, Debapriya Mondal, Prashant Pandey, Deepak Dabkara, Bivas Biswas

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in JCO global oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Oncology patients' perceptions of and experiences with COVID-19.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Joydeep GhoshDepartment of Medical Oncology, Tata Medical Center, Kolkata, West Bengal, India.
Sandip GangulyDepartment of Medical Oncology, Tata Medical Center, Kolkata, West Bengal, India.
Debapriya MondalDepartment of Medical Oncology, Tata Medical Center, Kolkata, West Bengal, India.
Prashant PandeyDepartment of Medical Oncology, Tata Medical Center, Kolkata, West Bengal, India.
Deepak DabkaraDepartment of Medical Oncology, Tata Medical Center, Kolkata, West Bengal, India.
Bivas BiswasDepartment of Medical Oncology, Tata Medical Center, Kolkata, West Bengal, India.
Tata Medical Center · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe coronavirus disease 2019 (COVID-19) pandemic has imposed a unique challenge to oncology patients and their treatment. There is no study related to the patients' preference for systemic therapy during this pandemic. We have conducted a prospective study to analyze that aspect.

methodsAll consecutive patients who visited during the lockdown period from April 1-10, 2020, for systemic chemotherapy were included in the study for a questionnaire-based survey to evaluate the willingness to continue chemotherapy during this pandemic and factors influencing the decisions.

resultsA total of 302 patients were included (median age, 56 years; range, 21-77 years). Most common sites of cancer were breast (n = 114), lung (n = 44), ovary (n = 34), and colon (n = 20). Home address was within the city for 125 patients (42%), outside the city for 138 (46%), and outside the state for 37 (12%). Treatment was curative in 150 patients and palliative in 152. Educational status was primary and above for 231 patients and no formal schooling for 71. A total of 203 patients wanted to continue chemotherapy, 40 wanted to defer, and 56 wanted the physician to decide. Knowledge about COVID-19 strongly correlated with intent of treatment (

conclusionThis study shows that oncology patients in our country are more worried about disease progression than the SARS-CoV-2 and wish to continue chemotherapy during this pandemic. The treatment guidelines in the COVID-19 scenario should incorporate patients' perspectives.

Indexed as

AdultAgedAntineoplastic Agents, ImmunologicalBetacoronavirusCoronavirus InfectionsCOVID-19Disease ProgressionFemaleHealth Knowledge, Attitudes, PracticeHumansImmunotherapyIndiaMaleMiddle AgedNeoplasmsPalliative CareAntineoplastic Agents, Immunological

Identifiers

PMID32552110
PMCPMC7328097
OpenAlexW3036111074

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.